<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-04-27" modified="2020-10-07" version="206">
<accession>Q9UQ80</accession>
<accession>O43846</accession>
<accession>Q9UM59</accession>
<name>PA2G4_HUMAN</name>
<protein>
<recommendedName>
<fullName>Proliferation-associated protein 2G4</fullName>
</recommendedName>
<alternativeName>
<fullName>Cell cycle protein p38-2G4 homolog</fullName>
<shortName>hG4-1</shortName>
</alternativeName>
<alternativeName>
<fullName>ErbB3-binding protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PA2G4</name>
<name type="synonym">EBP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Cytogenet. Cell Genet." volume="78" first="31" last="35">
<title>Molecular cloning and mapping of a human cDNA (PA2G4) that encodes a protein highly homologous to the mouse cell cycle protein p38-2G4.</title>
<authorList>
<person name="Lamartine J."/>
<person name="Seri M."/>
<person name="Cinti R."/>
<person name="Heitzmann F."/>
<person name="Creaven M."/>
<person name="Radomski N."/>
<person name="Jost E."/>
<person name="Lenoir G.M."/>
<person name="Romeo G."/>
<person name="Sylla B.S."/>
</authorList>
<dbReference type="PubMed" id="9345902"/>
<dbReference type="DOI" id="10.1159/000134621"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Br. J. Cancer" volume="82" first="683" last="690">
<title>Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin.</title>
<authorList>
<person name="Yoo J.Y."/>
<person name="Wang X.W."/>
<person name="Rishi A.K."/>
<person name="Lessor T."/>
<person name="Xia X.M."/>
<person name="Gustafson T.A."/>
<person name="Hamburger A.W."/>
</authorList>
<dbReference type="PubMed" id="10682683"/>
<dbReference type="DOI" id="10.1054/bjoc.1999.0981"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>INTERACTION WITH ERBB3</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="1998-11" db="EMBL/GenBank/DDBJ databases">
<title>Genomic structure of the human PA2G4 gene.</title>
<authorList>
<person name="Caroli F."/>
<person name="Lamartine J."/>
<person name="Sylla B.S."/>
<person name="Romeo G."/>
<person name="Seri M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2010-01" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Matallanas D."/>
<person name="Cooper W.N."/>
<person name="Boldt K."/>
<person name="von Kriegsheim A.F."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-20; 23-30; 34-62; 73-101; 156-172; 200-211; 216-236; 264-281 AND 299-364</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT SER-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>B-cell lymphoma</tissue>
<tissue>Mammary carcinoma</tissue>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Afjehi-Sadat L."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 34-51; 216-236; 264-271; 299-311; 333-344 AND 377-394</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Cajal-Retzius cell</tissue>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Mol. Cell. Endocrinol." volume="175" first="185" last="191">
<title>Regulation of the ErbB3 binding protein Ebp1 by protein kinase C.</title>
<authorList>
<person name="Lessor T.J."/>
<person name="Hamburger A.W."/>
</authorList>
<dbReference type="PubMed" id="11325528"/>
<dbReference type="DOI" id="10.1016/s0303-7207(01)00387-2"/>
</citation>
<scope>INTERACTION WITH ERBB3</scope>
<scope>PHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION BY PKC</scope>
<scope>PHOSPHORYLATION AT THR-366</scope>
<scope>MUTAGENESIS OF SER-363 AND THR-366</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="J. Cell. Physiol." volume="187" first="209" last="217">
<title>Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation.</title>
<authorList>
<person name="Xia X."/>
<person name="Cheng A."/>
<person name="Lessor T."/>
<person name="Zhang Y."/>
<person name="Hamburger A.W."/>
</authorList>
<dbReference type="PubMed" id="11268000"/>
<dbReference type="DOI" id="10.1002/jcp.1075"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTION REPRESSION</scope>
<scope>INTERACTION WITH RB1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="4100" last="4109">
<title>Functional proteomic analysis of human nucleolus.</title>
<authorList>
<person name="Scherl A."/>
<person name="Coute Y."/>
<person name="Deon C."/>
<person name="Calle A."/>
<person name="Kindbeiter K."/>
<person name="Sanchez J.-C."/>
<person name="Greco A."/>
<person name="Hochstrasser D.F."/>
<person name="Diaz J.-J."/>
</authorList>
<dbReference type="PubMed" id="12429849"/>
<dbReference type="DOI" id="10.1091/mbc.e02-05-0271"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Nucleic Acids Res." volume="31" first="2168" last="2177">
<title>Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Woodford N."/>
<person name="Xia X."/>
<person name="Hamburger A.W."/>
</authorList>
<dbReference type="PubMed" id="12682367"/>
<dbReference type="DOI" id="10.1093/nar/gkg318"/>
</citation>
<scope>FUNCTION IN E2F1-MEDIATED TRANSCRIPTION REPRESSION</scope>
<scope>INTERACTION WITH HDAC2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="4454" last="4465">
<title>EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes.</title>
<authorList>
<person name="Squatrito M."/>
<person name="Mancino M."/>
<person name="Donzelli M."/>
<person name="Areces L.B."/>
<person name="Draetta G.F."/>
</authorList>
<dbReference type="PubMed" id="15064750"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207579"/>
</citation>
<scope>FUNCTION IN RRNA PROCESSING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>RNA-BINDING</scope>
<scope>IDENTIFICATION IN A RIBONUCLEOPROTEIN COMPLEX</scope>
<scope>ASSOCIATION WITH RRNA</scope>
<scope>ASSOCIATION WITH U3 SNORNA</scope>
<scope>MUTAGENESIS OF 20-LYS--LYS-22 AND 364-ARG-LYS-365</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Br. J. Cancer" volume="92" first="140" last="146">
<title>Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Hamburger A.W."/>
</authorList>
<dbReference type="PubMed" id="15583694"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6602257"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTION REPRESSION</scope>
<scope>INTERACTION WITH ERBB3 AND AR</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND THR-386</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-386</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="10917" last="10922">
<title>Ebp1 isoforms distinctively regulate cell survival and differentiation.</title>
<authorList>
<person name="Liu Z."/>
<person name="Ahn J.Y."/>
<person name="Liu X."/>
<person name="Ye K."/>
</authorList>
<dbReference type="PubMed" id="16832058"/>
<dbReference type="DOI" id="10.1073/pnas.0602923103"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORMS 1 AND 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ERBB3</scope>
<scope>PHOSPHORYLATION AT SER-361</scope>
<scope>MUTAGENESIS OF SER-361</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361 AND THR-386</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Mol. Biol. Cell" volume="20" first="757" last="768">
<title>Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor.</title>
<authorList>
<person name="Liu Z."/>
<person name="Oh S.M."/>
<person name="Okada M."/>
<person name="Liu X."/>
<person name="Cheng D."/>
<person name="Peng J."/>
<person name="Brat D.J."/>
<person name="Sun S.Y."/>
<person name="Zhou W."/>
<person name="Gu W."/>
<person name="Ye K."/>
</authorList>
<dbReference type="PubMed" id="19037095"/>
<dbReference type="DOI" id="10.1091/mbc.e08-09-0983"/>
</citation>
<scope>POLYUBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH RNF20 AND HUWE1</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF SER-361</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-386</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-361 AND THR-386</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND THR-386</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-335 AND SER-361</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2016" name="Am. J. Hum. Genet." volume="99" first="115" last="124">
<title>DNAJC21 mutations link a cancer-prone bone marrow failure syndrome to corruption in 60S ribosome subunit maturation.</title>
<authorList>
<person name="Tummala H."/>
<person name="Walne A.J."/>
<person name="Williams M."/>
<person name="Bockett N."/>
<person name="Collopy L."/>
<person name="Cardoso S."/>
<person name="Ellison A."/>
<person name="Wynn R."/>
<person name="Leblanc T."/>
<person name="Fitzgibbon J."/>
<person name="Kelsell D.P."/>
<person name="van Heel D.A."/>
<person name="Payne E."/>
<person name="Plagnol V."/>
<person name="Dokal I."/>
<person name="Vulliamy T."/>
</authorList>
<dbReference type="PubMed" id="27346687"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2016.05.002"/>
</citation>
<scope>INTERACTION WITH DNAJC21</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-298</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="4450" last="4454">
<title>The crystal structure of Ebp1 reveals a methionine aminopeptidase fold as binding platform for multiple interactions.</title>
<authorList>
<person name="Kowalinski E."/>
<person name="Bange G."/>
<person name="Bradatsch B."/>
<person name="Hurt E."/>
<person name="Wild K."/>
<person name="Sinning I."/>
</authorList>
<dbReference type="PubMed" id="17765895"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.08.024"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS)</scope>
<scope>INTERACTION WITH 5S RIBOSOMAL RNA</scope>
<scope>LACK OF AMINOPEPTIDASE ACTIVITY</scope>
</reference>
<comment type="function">
<text evidence="13 14 16 18 19 20 21">May play a role in a ERBB3-regulated signal transduction pathway. Seems be involved in growth regulation. Acts a corepressor of the androgen receptor (AR) and is regulated by the ERBB3 ligand neuregulin-1/heregulin (HRG). Inhibits transcription of some E2F1-regulated promoters, probably by recruiting histone acetylase (HAT) activity. Binds RNA. Associates with 28S, 18S and 5.8S mature rRNAs, several rRNA precursors and probably U3 small nucleolar RNA. May be involved in regulation of intermediate and late steps of rRNA processing. May be involved in ribosome assembly. Mediates cap-independent translation of specific viral IRESs (internal ribosomal entry site) (By similarity). Regulates cell proliferation, differentiation, and survival. Isoform 1 suppresses apoptosis whereas isoform 2 promotes cell differentiation (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="14 15 16 17 18 19 20 21 22 23 24">Isoform 2 interacts with the cytoplasmic domain of non-phosphorylated ERBB3; the interaction requires PKC activity. Interacts with AR. Treatment with HRG leads to dissociation from ERBB3 and increases association with AR. Interacts with NCL/nucleolin. Component of a ribonucleoprotein complex containing at least PA2G4, NCL, TOP1, PABPC2, RPLP0, acetylated histone H1 (HIST1H1A or H1F1), histone H1 2/4, RPL4, RPL8, RPL15, RPL18, RPL18A, RPL21, RPL11, RPL12, RPL28, RPL27, RPLP2 and RPL24. Interacts with HDAC2. Interacts with RB1; the interaction is enhanced upon PA2G4 dephosphorylation. Interacts with AKT1 (By similarity). Isoform 1 and isoform 2 interact with RNF20. Isoform 2 interacts with HUWE1. Interacts with DNAJC21 (PubMed:27346687).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-924893">
<id>Q9UQ80</id>
</interactant>
<interactant intactId="EBI-346967">
<id>P19338</id>
<label>NCL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-924893">
<id>Q9UQ80</id>
</interactant>
<interactant intactId="EBI-491274">
<id>P06400</id>
<label>RB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-924893">
<id>Q9UQ80</id>
</interactant>
<interactant intactId="EBI-347218">
<id>Q96ST3</id>
<label>SIN3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="21 23">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21 23">Nucleus</location>
<location evidence="21 23">Nucleolus</location>
</subcellularLocation>
<text evidence="21">Translocates to the nucleus upon treatment with HRG. Phosphorylation at Ser-361 by PKC/PRKCD regulates its nucleolar localization.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="21 23">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9UQ80-1</id>
<name evidence="27">1</name>
<name evidence="26">p48</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9UQ80-2</id>
<name evidence="27">2</name>
<name evidence="26">p42</name>
<sequence type="described" ref="VSP_057325"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="15 19 23">Isoform 2 is undetectable whereas isoform 1 is strongly expressed in cancer cells (at protein level). Isoform 1 and isoform 2 are widely expressed, including heart, brain, lung, pancreas, skeletal muscle, kidney, placenta and liver.</text>
</comment>
<comment type="PTM">
<text evidence="17 21 23">Phosphorylated on serine and threonine residues. Phosphorylation is enhanced by HRG treatment. Basal phosphorylation is PKC-dependent and HRG-induced phosphorylation is predominantly PKC-independent. Phosphorylation at Ser-361 by PKC/PRKCD regulates its nucleolar localization.</text>
</comment>
<comment type="PTM">
<text evidence="23">In cancer cells, isoform 2 is polyubiquitinated leading to its proteasomal degradation and phosphorylation by PKC/PRKCD enhances polyubiquitination.</text>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the peptidase M24 family.</text>
</comment>
<comment type="caution">
<text evidence="29">Although it belongs to the peptidase M24 family, it does not contain metal cofactors and lacks aminopeptidase activity.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PA2G4ID41628ch12q13.html"/>
</comment>
<dbReference type="EMBL" id="U59435">
<property type="protein sequence ID" value="AAB91536.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87954">
<property type="protein sequence ID" value="AAD00646.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF104670">
<property type="protein sequence ID" value="AAD05561.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF104668">
<property type="protein sequence ID" value="AAD05561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF104669">
<property type="protein sequence ID" value="AAD05561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001951">
<property type="protein sequence ID" value="AAH01951.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007561">
<property type="protein sequence ID" value="AAH07561.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC069786">
<property type="protein sequence ID" value="AAH69786.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8902.1">
<molecule id="Q9UQ80-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006182.2">
<molecule id="Q9UQ80-1"/>
<property type="nucleotide sequence ID" value="NM_006191.2"/>
</dbReference>
<dbReference type="PDB" id="2Q8K">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=2-394"/>
</dbReference>
<dbReference type="PDB" id="3J2I">
<property type="method" value="EM"/>
<property type="resolution" value="11.90"/>
<property type="chains" value="A=1-394"/>
</dbReference>
<dbReference type="PDB" id="6CHT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.17"/>
<property type="chains" value="C/F/I/L=349-368"/>
</dbReference>
<dbReference type="PDB" id="6SXO">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=1-394"/>
</dbReference>
<dbReference type="PDBsum" id="2Q8K"/>
<dbReference type="PDBsum" id="3J2I"/>
<dbReference type="PDBsum" id="6CHT"/>
<dbReference type="PDBsum" id="6SXO"/>
<dbReference type="SMR" id="Q9UQ80"/>
<dbReference type="BioGRID" id="111075">
<property type="interactions" value="173"/>
</dbReference>
<dbReference type="DIP" id="DIP-31275N"/>
<dbReference type="ELM" id="Q9UQ80"/>
<dbReference type="IntAct" id="Q9UQ80">
<property type="interactions" value="83"/>
</dbReference>
<dbReference type="MINT" id="Q9UQ80"/>
<dbReference type="STRING" id="9606.ENSP00000302886"/>
<dbReference type="MEROPS" id="M24.973"/>
<dbReference type="iPTMnet" id="Q9UQ80"/>
<dbReference type="MetOSite" id="Q9UQ80"/>
<dbReference type="PhosphoSitePlus" id="Q9UQ80"/>
<dbReference type="SwissPalm" id="Q9UQ80"/>
<dbReference type="BioMuta" id="PA2G4"/>
<dbReference type="DMDM" id="13632817"/>
<dbReference type="SWISS-2DPAGE" id="Q9UQ80"/>
<dbReference type="EPD" id="Q9UQ80"/>
<dbReference type="jPOST" id="Q9UQ80"/>
<dbReference type="MassIVE" id="Q9UQ80"/>
<dbReference type="PaxDb" id="Q9UQ80"/>
<dbReference type="PeptideAtlas" id="Q9UQ80"/>
<dbReference type="PRIDE" id="Q9UQ80"/>
<dbReference type="ProteomicsDB" id="85517">
<molecule id="Q9UQ80-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="3192">
<property type="antibodies" value="419 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5036"/>
<dbReference type="Ensembl" id="ENST00000303305">
<molecule id="Q9UQ80-1"/>
<property type="protein sequence ID" value="ENSP00000302886"/>
<property type="gene ID" value="ENSG00000170515"/>
</dbReference>
<dbReference type="GeneID" id="5036"/>
<dbReference type="KEGG" id="hsa:5036"/>
<dbReference type="UCSC" id="uc001sjm.4">
<molecule id="Q9UQ80-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5036"/>
<dbReference type="DisGeNET" id="5036"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000170515.13"/>
<dbReference type="GeneCards" id="PA2G4"/>
<dbReference type="HGNC" id="HGNC:8550">
<property type="gene designation" value="PA2G4"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000170515">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="602145">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UQ80"/>
<dbReference type="OpenTargets" id="ENSG00000170515"/>
<dbReference type="PharmGKB" id="PA32877"/>
<dbReference type="eggNOG" id="KOG2776">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154281"/>
<dbReference type="HOGENOM" id="CLU_041451_2_1_1"/>
<dbReference type="InParanoid" id="Q9UQ80"/>
<dbReference type="OMA" id="FPFAERW"/>
<dbReference type="PhylomeDB" id="Q9UQ80"/>
<dbReference type="TreeFam" id="TF300010"/>
<dbReference type="PathwayCommons" id="Q9UQ80"/>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q9UQ80"/>
<dbReference type="BioGRID-ORCS" id="5036">
<property type="hits" value="201 hits in 866 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PA2G4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9UQ80"/>
<dbReference type="GeneWiki" id="PA2G4"/>
<dbReference type="GenomeRNAi" id="5036"/>
<dbReference type="Pharos" id="Q9UQ80">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9UQ80"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="Q9UQ80">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000170515">
<property type="expression patterns" value="Expressed in tonsil and 249 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9UQ80">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UQ80">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0035578">
<property type="term" value="C:azurophil granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003676">
<property type="term" value="F:nucleic acid binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045597">
<property type="term" value="P:positive regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006417">
<property type="term" value="P:regulation of translation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006364">
<property type="term" value="P:rRNA processing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.230.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036005">
<property type="entry name" value="Creatinase/aminopeptidase-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR004545">
<property type="entry name" value="PA2G4"/>
</dbReference>
<dbReference type="InterPro" id="IPR000994">
<property type="entry name" value="Pept_M24"/>
</dbReference>
<dbReference type="InterPro" id="IPR018349">
<property type="entry name" value="Pept_M24A_MAP2_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00557">
<property type="entry name" value="Peptidase_M24"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55920">
<property type="entry name" value="SSF55920"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00495">
<property type="entry name" value="crvDNA_42K"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01202">
<property type="entry name" value="MAP_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0687">Ribonucleoprotein</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0698">rRNA processing</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0810">Translation regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="5 7 8 9 10 25">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Proliferation-associated protein 2G4" id="PRO_0000148989">
<location>
<begin position="2"/>
<end position="394"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for nucleolar localization" evidence="19">
<location>
<begin position="2"/>
<end position="48"/>
</location>
</feature>
<feature type="region of interest" description="RNA-binding" evidence="19">
<location>
<begin position="46"/>
<end position="54"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for nucleolar localization" evidence="19">
<location>
<begin position="301"/>
<end position="394"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RNA" evidence="13">
<location>
<begin position="361"/>
<end position="375"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="5 7 8 9 10 25">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 7 8 11">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="335"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC/PRKCD" evidence="4 7 11 21">
<location>
<position position="361"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="28">
<location>
<position position="366"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2 3 4 6 7 8">
<location>
<position position="386"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="298"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_057325" evidence="21">
<location>
<begin position="1"/>
<end position="54"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of nucleolar localization." evidence="19">
<original>KYK</original>
<variation>AYA</variation>
<location>
<begin position="20"/>
<end position="22"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation and interaction with ERBB3 and HUWE1." evidence="21">
<original>S</original>
<variation>A</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation and loss of nucleolar localization." evidence="21">
<original>S</original>
<variation>D</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by PKC." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only partial nucleolar localization." evidence="19">
<original>RK</original>
<variation>AA</variation>
<location>
<begin position="364"/>
<end position="365"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases in vitro phosphorylation by PKC." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB91536." ref="1" evidence="27">
<original>A</original>
<variation>P</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="15"/>
<end position="38"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="45"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="72"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="85"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="105"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="117"/>
<end position="126"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="137"/>
<end position="156"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="163"/>
<end position="175"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="176"/>
<end position="178"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="186"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="194"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="200"/>
<end position="204"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="207"/>
<end position="212"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="223"/>
<end position="233"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="246"/>
<end position="249"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="260"/>
<end position="273"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="280"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="287"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="301"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="316"/>
<end position="326"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="329"/>
<end position="332"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="340"/>
<end position="342"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="352"/>
<end position="359"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Q8K"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P50580"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q6AYD3"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10682683"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11268000"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11325528"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12682367"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15064750"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15583694"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16832058"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17765895"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19037095"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27346687"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16832058"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11325528"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17765895"/>
</source>
</evidence>
<sequence length="394" mass="43787" checksum="CD45466507AD6047" modified="2007-01-23" version="3">MSGEDEQQEQTIAEDLVVTKYKMGGDIANRVLRSLVEASSSGVSVLSLCEKGDAMIMEETGKIFKKEKEMKKGIAFPTSISVNNCVCHFSPLKSDQDYILKEGDLVKIDLGVHVDGFIANVAHTFVVDVAQGTQVTGRKADVIKAAHLCAEAALRLVKPGNQNTQVTEAWNKVAHSFNCTPIEGMLSHQLKQHVIDGEKTIIQNPTDQQKKDHEKAEFEVHEVYAVDVLVSSGEGKAKDAGQRTTIYKRDPSKQYGLKMKTSRAFFSEVERRFDAMPFTLRAFEDEKKARMGVVECAKHELLQPFNVLYEKEGEFVAQFKFTVLLMPNGPMRITSGPFEPDLYKSEMEVQDAELKALLQSSASRKTQKKKKKKASKTAENATSGETLEENEAGD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

